Jext Auto-Injector

Jext is a pre-filled adrenaline (epinephrine) auto-injector designed for emergency use during life-threatening allergic reactions known as anaphylaxis. It contains a sterile solution for intramuscular injection into the outer thigh. Jext is prescribed for people with known severe allergies to foods, insect stings, medications, or for exercise-induced anaphylaxis. When used promptly at the first signs of a severe reaction, it can reverse dangerous symptoms, potentially saving lives.
Complete a short online consultation so our prescriber can confirm the treatment suits you.
The decision to supply the specific treatment and quantity requested will be based on whether our medical team are satisfied that it will be safe, appropriate, and effective.
Or 3 interest-free payments of £30.00 via Klarna
Tracked 24 Delivery3 interest-free payments via KlarnaDiscreet packaging

Jext Treatment

Product NameJext
ManufacturerALK-Abelló A/S
Active IngredientAdrenaline (Epinephrine)
AdministrationIntramuscular injection (auto-injector)
PresentationPre-filled pen with safety cap and carry case
Available Strengths150mcg / 1 Injection, 300mcg / 1 Injection
Product TypePOM — Prescription Only
Suitable for pregnancy?Emergency Use Only
Use with alcoholCaution advised - alcohol can increase adrenaline effects
Link to Patient Information LeafletJext PIL ↗
Authored byNabeel

Medical Content Officer

Nabeel is a co-founder, and medical content officer of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Talal is a GMC registered doctor and medical content reviewer at Chemist Doctor. He ensures clinical accuracy and reliability across health content.

Approved byUsman

Medical Administrative Officer

Usman is a co-founder, and medical administrative officer of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical administration and operational priorities.

Review Date: 2 Jul 2026

Next Review: 1 Jan 2027

Published on: 19 Nov 2025

Last Updated: 3 Jul 2026